197 related articles for article (PubMed ID: 37085406)
1. QT prolongation, torsades des pointes, and cardiac arrest after 4 mg of IV ondansetron.
Orozco BS; Lee SC; Fuchs RT; Fushianes GD; Cole JB
Am J Emerg Med; 2023 Jun; 68():214.e3-214.e6. PubMed ID: 37085406
[TBL] [Abstract][Full Text] [Related]
2. The Incidence of QT Prolongation and Torsades des Pointes in Patients Receiving Droperidol in an Urban Emergency Department.
Cole JB; Lee SC; Martel ML; Smith SW; Biros MH; Miner JR
West J Emerg Med; 2020 Jul; 21(4):728-736. PubMed ID: 32726229
[TBL] [Abstract][Full Text] [Related]
3. Torsades de Pointes after Ondansetron Infusion in 2 Patients.
Lee DY; Trinh T; Roy SK
Tex Heart Inst J; 2017 Oct; 44(5):366-369. PubMed ID: 29259513
[TBL] [Abstract][Full Text] [Related]
4. [Drug induced QT prolongation].
Altmann D; Eggmann U; Ammann P
Wien Klin Wochenschr; 2008; 120(5-6):128-35. PubMed ID: 18365152
[TBL] [Abstract][Full Text] [Related]
5. Emergency department approach to QTc prolongation.
Pourmand A; Mazer-Amirshahi M; Chistov S; Sabha Y; Vukomanovic D; Almulhim M
Am J Emerg Med; 2017 Dec; 35(12):1928-1933. PubMed ID: 28855066
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of QT interval prolongation in patients admitted to cardiac care units and frequency of subsequent administration of QT interval-prolonging drugs: a prospective, observational study in a large urban academic medical center in the US.
Tisdale JE; Wroblewski HA; Overholser BR; Kingery JR; Trujillo TN; Kovacs RJ
Drug Saf; 2012 Jun; 35(6):459-70. PubMed ID: 22612851
[TBL] [Abstract][Full Text] [Related]
7. Cardiac Arrest Following Torsades de Pointes Caused by Hypokalemia and Catecholamines in a Patient with Congenital Long QT Syndrome Type 1 After Surgical Aortic Valve Replacement: A Case Report.
Kitaura A; Nakao S; Yuasa H; Tsukimoto S; Nakajima Y
Am J Case Rep; 2022 Dec; 23():e938609. PubMed ID: 36523136
[TBL] [Abstract][Full Text] [Related]
8. Vomiting, electrolyte disturbance, and medications; the perfect storm for acquired long QT syndrome and cardiac arrest: a case report.
Tiver KD; Dharmaprani D; Quah JX; Lahiri A; Waddell-Smith KE; Ganesan AN
J Med Case Rep; 2022 Jan; 16(1):9. PubMed ID: 35012656
[TBL] [Abstract][Full Text] [Related]
9. Torsades de pointes induced by concomitant use of chlorpheniramine and propranolol: An unusual presentation with no QT prolongation.
Ösken A; Yelgeç NS; Zehir R; Öz TK; Yaylacı S; Akdemir R; Gündüz H
Indian J Pharmacol; 2016; 48(4):462-465. PubMed ID: 27756965
[TBL] [Abstract][Full Text] [Related]
10. Small doses of droperidol do not present relevant torsadogenic actions: a double-blind, ondansetron-controlled study.
Tracz K; Owczuk R
Br J Clin Pharmacol; 2015 Apr; 79(4):669-76. PubMed ID: 25293524
[TBL] [Abstract][Full Text] [Related]
11. The incidence of torsades de pointes with peri-operative low-dose ondansetron administration.
Nuttall GA; Voogd SC; Danke H; Warner PA; Oyen LJ; Marienau MS; Ackerman MJ
Pharmacotherapy; 2022 Apr; 42(4):292-297. PubMed ID: 35124842
[TBL] [Abstract][Full Text] [Related]
12. QT interval prolongation and the risk of torsades de pointes: essentials for clinicians.
Trinkley KE; Page RL; Lien H; Yamanouye K; Tisdale JE
Curr Med Res Opin; 2013 Dec; 29(12):1719-26. PubMed ID: 24020938
[TBL] [Abstract][Full Text] [Related]
13. Increased ventricular ectopy precedes Torsades de Pointes in patients with prolonged QT.
Marill KA; Lopez S; Hark D; Spahr J; Kapadia N; Liu SW
J Electrocardiol; 2023; 80():17-23. PubMed ID: 37105125
[TBL] [Abstract][Full Text] [Related]
14. Medical toxicologists' practice patterns regarding drug-induced QT prolongation in overdose patients: a survey in the United States of America, Europe, and Asia Pacific region.
Othong R; Devlin JJ; Kazzi ZN
Clin Toxicol (Phila); 2015 May; 53(4):204-9. PubMed ID: 25706450
[TBL] [Abstract][Full Text] [Related]
15. Effect of intravenous ondansetron on QT interval prolongation in patients with cardiovascular disease and additional risk factors for torsades: a prospective, observational study.
Hafermann MJ; Namdar R; Seibold GE; Page RL
Drug Healthc Patient Saf; 2011; 3():53-8. PubMed ID: 22046106
[TBL] [Abstract][Full Text] [Related]
16. Ciprofloxacin induced acquired long QT syndrome in a patient under class III antiarrhythmic therapy.
Keivanidou A; Arnaoutoglou C; Krommydas A; Papanikolaou G; Tsiptses K; Chrisopoulos C; Kirpizidis C
Cardiol J; 2009; 16(2):172-4. PubMed ID: 19387967
[TBL] [Abstract][Full Text] [Related]
17. Hyperglycemia and subsequent torsades de pointes with marked QT prolongation during refeeding.
Nakashima T; Kubota T; Takasugi N; Kitagawa Y; Yoshida T; Ushikoshi H; Kawasaki M; Nishigaki K; Ogura S; Minatoguchi S
Nutrition; 2017 Jan; 33():145-148. PubMed ID: 27544004
[TBL] [Abstract][Full Text] [Related]
18. Citalopram overdose: late presentation of torsades de pointes (TdP) with cardiac arrest.
Tarabar AF; Hoffman RS; Nelson L
J Med Toxicol; 2008 Jun; 4(2):101-5. PubMed ID: 18570170
[TBL] [Abstract][Full Text] [Related]
19. Torsades de pointes following clarithromycin treatment.
Gysel M; Vieweg WV; Hasnain M; Hancox JC; Kunanithy V; Baranchuk A
Expert Rev Cardiovasc Ther; 2013 Nov; 11(11):1485-93. PubMed ID: 24147515
[TBL] [Abstract][Full Text] [Related]
20. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
